Q2 FY26Published 14 Nov 2025Call held 14 Nov 2025
EXPLEOSOL Q2 FY26 Earnings Call Transcript & Analysis
Operating Revenue2,827 million+9% YoYEBITDA Margin17.1%Total Income2,954 million+9% YoY
Operating Revenue 2827 million (+9% YoY); EBITDA Margin 17.1%; Total Income 2954 million (+9% YoY). Operating Revenue grew 8.9% QoQ to INR 2,827 million.
Read full transcript & analysis